Article Type
Changed
Wed, 02/20/2019 - 09:54

 

When a patient told Richard Balon, MD, that he could no longer afford to spend $300 a month on a tricyclic, Dr. Balon could not believe that the price was so high. “This is clearly unsustainable,” said Dr. Balon, professor of psychiatry and anesthesiology, and associate chair of education at Wayne State University in Detroit. In this Masterclass episode of the Psychcast from the 2018 AACP Encore meeting in Las Vegas, he lectures on the increase in the price of generic and brand name medications in the United States.

Amazon

Apple Podcasts

Google Podcasts

Spotify



 

Publications
Sections

 

When a patient told Richard Balon, MD, that he could no longer afford to spend $300 a month on a tricyclic, Dr. Balon could not believe that the price was so high. “This is clearly unsustainable,” said Dr. Balon, professor of psychiatry and anesthesiology, and associate chair of education at Wayne State University in Detroit. In this Masterclass episode of the Psychcast from the 2018 AACP Encore meeting in Las Vegas, he lectures on the increase in the price of generic and brand name medications in the United States.

Amazon

Apple Podcasts

Google Podcasts

Spotify



 

 

When a patient told Richard Balon, MD, that he could no longer afford to spend $300 a month on a tricyclic, Dr. Balon could not believe that the price was so high. “This is clearly unsustainable,” said Dr. Balon, professor of psychiatry and anesthesiology, and associate chair of education at Wayne State University in Detroit. In this Masterclass episode of the Psychcast from the 2018 AACP Encore meeting in Las Vegas, he lectures on the increase in the price of generic and brand name medications in the United States.

Amazon

Apple Podcasts

Google Podcasts

Spotify



 

Publications
Publications
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica